MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco Pharmaceuticals ETF (NY:PJP)

122.82 +2.22 (+1.84%)
Streaming Delayed Price Updated: 11:26 AM EDT, Jul 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 29,124
Open 122.53
Bid (Size) 122.63 (1,300)
Ask (Size) 122.75 (200)
Prev. Close 120.60
Today's Range 122.35 - 123.23
52wk Range 80.63 - 122.69
Shares Outstanding 28,900
Dividend Yield 0.89%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
As Healthcare Rallies Is the Vanguard Health Care ETF of the Invesco Pharmaceuticals ETF the Better Fund for 2026? ↗
PJP surged 45% in one year, but VHT's lower costs and higher dividend yield appeal to long-term income investors seeking broad sector exposure. 
Via The Motley Fool
Topics ETFs
News headline image
Will the Invesco Pharma ETF or iShares Global Healthcare Fund Be the Better Health Care Fund in 2026? ↗
IXJ offers broader diversification with 110 holdings and a lower 0.40% expense ratio, while PJP's concentrated U.S. pharma strategy delivered a 44.90% one-year return. 
Via The Motley Fool
Topics ETFs

Performance

YTD
+17.7%
+17.7%
1 Month
+3.5%
+3.5%
3 Month
+18.3%
+18.3%
6 Month
+16.2%
+16.2%
1 Year
+46.8%
+46.8%

More News

Read More
News headline image
PJP vs. IYH: Which Healthcare ETF Is the Better Buy? ↗
Via The Motley Fool
Topics ETFs
Merck’s Blockbuster Drug Keytruda Gets Canadian Regulator’s Approval For Treating Cervical Cancer: Retail Investors Appear Divided ↗
Via Stocktwits
News headline image
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
Invesco Pharmaceuticals ETF or First Trust Biotech Fund: Which Drug Maker-Focused Fund Should You Buy in 2026? ↗
Via The Motley Fool
Topics ETFs
News headline image
IHE vs. PJP: Which Pharmaceutical ETF Is the Better Buy for Investors? ↗
Via The Motley Fool
Topics ETFs Intellectual Property
News headline image
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP? ↗
Via The Motley Fool
Topics ETFs
News headline image
State Street Health Care ETF Tops Invesco Pharma on Cost and Size ↗
Via The Motley Fool
Topics ETFs
News headline image
Invesco's RSPH vs. PJP: Which Health Care ETF Is the Better Fund For The GLP-1 Revolution? ↗
Via The Motley Fool
Topics ETFs
News headline image
Healthcare ETFs: PJP Focuses on Pharmaceuticals, While XBI Zeroes in on Biotech ↗
Via The Motley Fool
Topics ETFs
News headline image
Why Did CANF Stock Soar 40% In Pre-Market Today? ↗
Via Stocktwits
News headline image
Merck Is Reportedly Splitting Its Pharma Division As Keytruda Patent Nears 2028 Expiry ↗
Via Stocktwits
Topics Intellectual Property
News headline image
FDA Commissioner Raises Concerns About US Pharma Lagging Behind China In Drug Development ↗
Via Stocktwits
Topics ETFs Government
News headline image
Why Did OCUL Stock Jump 13% In Pre-Market Today? ↗
Via Stocktwits
News headline image
US-UK Near Landmark Zero-Tariffs Pharma Deal, Announcement Expected Soon: Report ↗
Via Stocktwits
Topics World Trade
News headline image
Eli Lilly CEO Slams PBM 'Rent Taking', Says They Drove Insulin List Prices To $275: 'We Can Disintermediate Them Easily' ↗
Via Benzinga
News headline image
Trump's 100% Drug Tariff Will Hit Americans, Economist Says Buyers 'Eat The Cost,' Not Foreign Firms ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Exposes How Wholesalers Force Pharmacies Into Near-Exclusive Deals, Detailing PBMs' 'Stranglehold' On Drug Pricing ↗
Via Benzinga
News headline image
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More' ↗
Via Benzinga
News headline image
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains' ↗
Via Benzinga
Topics Government World Trade
News headline image
FDA May Fast-Track New Drug Reviews In Return For Companies Lowering Drug Prices: Report ↗
Via Stocktwits
Topics Government
News headline image
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies ↗
Via Benzinga
Topics Government World Trade
News headline image
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare' ↗
Via Benzinga
News headline image
FDA Aims To Reduce Drug Application Review Time With New Voucher Program ↗
Via Stocktwits

Frequently Asked Questions

Is Invesco Pharmaceuticals ETF publicly traded?
Yes, Invesco Pharmaceuticals ETF is publicly traded.
What exchange does Invesco Pharmaceuticals ETF trade on?
Invesco Pharmaceuticals ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Pharmaceuticals ETF?
The ticker symbol for Invesco Pharmaceuticals ETF is PJP on the New York Stock Exchange
What is the current price of Invesco Pharmaceuticals ETF?
The current price of Invesco Pharmaceuticals ETF is 122.82
When was Invesco Pharmaceuticals ETF last traded?
The last trade of Invesco Pharmaceuticals ETF was at 07/28/26 11:26 AM ET
What is the market capitalization of Invesco Pharmaceuticals ETF?
The market capitalization of Invesco Pharmaceuticals ETF is 3.55M
How many shares of Invesco Pharmaceuticals ETF are outstanding?
Invesco Pharmaceuticals ETF has 4M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story